Metabolic-associated fatty liver disease raises risk of end-stage renal disease Dr. Kamal Kant Kohli9 Nov 2022 10:45 AM ISTCHINA: According to research reported in Acta Diabetologica, individuals with biopsy-proven diabetic nephropathy are at an increased risk of incident...
Psoriasis does not increase MI risk among patients with end stage renal disease Jacinthlyn Sylvia8 Nov 2022 8:00 PM ISTA new study published in The American Journal of the Medical Sciences shows that psoriasis was not linked to an elevated risk of myocardial infarction...
Discontinuing RAS inhibitors in advanced CKD doesn't slow decline in estimated GFR: NEJM Dr.Niharika Harsha B7 Nov 2022 8:00 PM ISTA new study found that discontinuation of Renin-angiotensin inhibitors in progressive and advanced end-stage kidney disease patients is not linked to...
UP: KGMU performs first combined liver-kidney transplant Kajal Rajput7 Nov 2022 5:45 PM ISTLucknow: The first combined liver-kidney transplant has been performed at the prestigious King George's Medical University (KGMU) after the family...
Empagliflozin reduces risk of disease progression and death in high-risk CKD patients: NEJM Medha Baranwal7 Nov 2022 10:30 AM ISTUK: Empagliflozin therapy in patients with chronic kidney disease (CKD) lowers the risk of disease progression or death from cardiovascular causes in...
Long term exposure to air pollution increases risk of developing CKD Dr. Kamal Kant Kohli6 Nov 2022 7:00 PM ISTChronic kidney disease (CKD) is a global disease burden related to high rates of incidence and mortality. It manifests as progressive and...
Kidney disease relapse after COVID-19 vaccination: JASN Study Isra Zaman5 Nov 2022 9:45 AM ISTPeople with glomerular diseases-a group of autoimmune kidney disease that often require long-term treatment with medications that suppress the...
Dapagliflozin effective from clinical standpoint as well as cost standpoint for CKD patients Dr. Kamal Kant Kohli5 Nov 2022 9:30 AM ISTThe burden of chronic kidney disease (CKD) to both healthcare systems and patients is considerable. Dapagliflozin, a sodium-glucose cotransporter-2...
Long-term exposure to air pollution can heighten kidney disease risk Isra Zaman5 Nov 2022 9:00 AM ISTAmong adults with normal kidney function, exposure to higher concentrations of components of air pollution was linked with higher risks of later...
Metastasectomy in renal cell carcinoma patients when and how? Jacinthlyn Sylvia3 Nov 2022 8:00 PM ISTMetastatic renal cell carcinoma has a variable natural history. Therefore treatment choice depends on disease and patient factors, but most...
Dapagliflozin clinically and cost effective in patients with chronic kidney disease: DAPA-CKD trial Isra Zaman3 Nov 2022 9:15 AM IST A recent analysis in CJASN indicates that in patients eligible for the DAPA-CKD trial, dapagliflozin is not only effective from a clinical...
Finerenone protects against adverse events among COVID-19 in patients with CKD and T2DM: JAMA Dr. Shravani Dali2 Nov 2022 12:00 PM ISTTreatment with Finerenone is effective against pneumonia and COVID-19 in patients with chronic kidney disease and type 2 diabetes suggests a recent...
